Alpha-1-syntrophin (SNTA1) (SNTA1)

Syntrophins are a family of intracellular peripheral membrane scaffold proteins, including Alpha, Beta, and Gamma isoforms, that serve as essential components of the dystrophin-associated glycoprotein complex (DGC). They function as modular adapters, utilizing PDZ and Pleckstrin homology (PH) domains to recruit and localize signaling molecules, such as neuronal nitric oxide synthase (nNOS) and the voltage-gated sodium channel Nav1.5, to specific membrane domains like the sarcolemma and neuromuscular junctions. Alpha-1-syntrophin (SNTA1) is the most prominent isoform in cardiac and skeletal muscle, where it is critical for maintaining electrical stability and structural integrity. Mutations in the SNTA1 gene are linked to Long QT syndrome type 12 and Sudden Infant Death Syndrome (SIDS) due to gain-of-function effects on sodium currents. In muscular dystrophies, the loss of dystrophin leads to a secondary deficiency of syntrophins, contributing to progressive muscle wasting and cardiomyopathy. While not currently targeted by approved small-molecule drugs, syntrophins are significant in research as biomarkers for cancer progression and as key components in gene therapies designed to restore the DGC in neuromuscular diseases.

Other names

Syntrophin alpha 1SNT1TACIP1LQT1259 kDa dystrophin-associated protein A1 acidic component 1Pro-TGF-alpha cytoplasmic domain-interacting protein 1

Jasplakinolide attenuates cell migration by impeding Alpha-1-syntrophin protein phosphorylation; Resveratrol indirectly modulates syntrophin-containing complexes by increasing utrophin expression.